MONTAGNESE, SARA
 Distribuzione geografica
Continente #
NA - Nord America 12.604
EU - Europa 1.193
AS - Asia 1.184
SA - Sud America 10
OC - Oceania 9
AF - Africa 3
Totale 15.003
Nazione #
US - Stati Uniti d'America 12.580
CN - Cina 506
SG - Singapore 490
IT - Italia 326
FI - Finlandia 230
VN - Vietnam 148
DE - Germania 138
SE - Svezia 136
GB - Regno Unito 130
FR - Francia 101
UA - Ucraina 51
ES - Italia 23
CA - Canada 19
IN - India 19
NL - Olanda 16
IE - Irlanda 14
GR - Grecia 6
AU - Australia 5
BG - Bulgaria 5
JP - Giappone 5
MX - Messico 5
BR - Brasile 4
NZ - Nuova Zelanda 4
HK - Hong Kong 3
KR - Corea 3
PE - Perù 3
BD - Bangladesh 2
CH - Svizzera 2
CL - Cile 2
EE - Estonia 2
HR - Croazia 2
LK - Sri Lanka 2
PH - Filippine 2
PL - Polonia 2
RO - Romania 2
TR - Turchia 2
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
IL - Israele 1
IR - Iran 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
NG - Nigeria 1
PT - Portogallo 1
RU - Federazione Russa 1
Totale 15.003
Città #
Fairfield 2.440
Woodbridge 1.451
Houston 1.049
Ashburn 912
Seattle 901
Cambridge 813
Wilmington 755
Ann Arbor 717
Chandler 702
Singapore 390
Boardman 307
Jacksonville 266
Santa Clara 235
Princeton 213
San Diego 181
Medford 164
Dong Ket 148
Padova 132
Roxbury 126
Des Moines 111
Beijing 105
Helsinki 95
Nanjing 81
Shenyang 38
London 32
New York 32
Guangzhou 31
Hebei 31
Jiaxing 27
Nanchang 23
Munich 21
Norwalk 21
Changsha 17
Pune 15
Dublin 13
Redwood City 13
Kilburn 10
Los Angeles 10
Tianjin 10
Jinan 9
Milan 9
Chicago 8
Ogden 8
Rome 8
Borås 7
Dearborn 7
Falls Church 7
Hounslow 7
Waltham Forest 7
Castelldefels 6
Haikou 6
Kharkiv 6
Rockville 6
Rubano 6
Amsterdam 5
Badalona 5
Camden 5
Lappeenranta 5
Longueuil 5
Naples 5
Nove 5
Shanghai 5
Sofia 5
Taizhou 5
Washington 5
Zhengzhou 5
Acton 4
Bologna 4
Brierley Hill 4
Chiswick 4
Culiacán 4
Hangzhou 4
Hefei 4
Jakobstad 4
Kunming 4
Montreal 4
Reggio Emilia 4
Sirmione 4
Trieste 4
Venice 4
Badajoz 3
Buffalo 3
Chengdu 3
Columbus 3
Cornate D'adda 3
Dallas 3
Frankfurt am Main 3
Hong Kong 3
Indiana 3
Islington 3
Lima 3
New Bedfont 3
Ningbo 3
Prescot 3
Sarmede 3
Southall 3
Stockholm 3
Tokyo 3
Agordo 2
Barcelona 2
Totale 12.919
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 194
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 185
Abnormalities in the 24-hour Rhythm of Skin Temperature in Cirrhosis: Sleep-Wake and General Clinical Implications 164
An educational tool for the prophylaxis of hepatic encephalopathy 155
A Model for Predicting Development of Overt Hepatic Encephalopathy in Patients With Cirrhosis 153
The Psychomotor Vigilance Task: Role in the Diagnosis of Hepatic Encephalopathy and Relationship with Driving Ability 151
A rare and revealing glimpse of the cerebrospinal fluid of patients with hepatic encephalopathy 148
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 146
The self-morningness/eveningness (Self-ME): An extremely concise and totally subjective assessment of diurnal preference 142
Changes in Accident & Emergency Visits and Return Visits in Relation to the Enforcement of Daylight Saving Time and Photoperiod 142
A SIMPLIFIED PSYCHOMETRIC EVALUATION FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY 139
The Application of the Extended Poincaré Plot in the Analysis of Physiological Variabilities 136
Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy 136
Reply to: "Tools and tactics for improving diagnosis of hepatic encephalopathy" 133
EASL Clinical Practice Guidelines on nutrition in chronic liver disease 133
Assessing inter- and intra-individual cognitive variability in patients at risk for cognitive impairment: the case of minimal hepatic encephalopathy 129
Sleep-wake profile in dementia with Lewy bodies, Alzheimer's disease, and normal aging. 128
A patients' and caregivers' perspective on hepatic encephalopathy. 127
Abnormal cerebral electrogenesis is associated with impaired cognitive performance in hypertensive patients 127
New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? 126
Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues 126
Clinical value of asterixis in 374 well-characterised patients with cirrhosis and varying degree of hepatic encephalopathy 126
Diurnal preference, mood and the response to morning light in relation to polymorphisms in the human clock gene PER3 124
Covert hepatic encephalopathy: agreement and predictive validity of different indices 123
Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine 123
Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes! 121
Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis. 121
Evaluation of a Modified Roche Enzymatic Ammonia Method for Roche Cobas 6000 (c501 Module) Automated Platform: When 5 µL Improves Performance 121
The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis 121
Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy 120
Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. 118
A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy 118
Electroencephalography in patients with cirrhosis. 114
The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology 110
Neurological complications after orthotopic liver transplantation 109
Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy. 107
Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. 106
Ammonia: The neglected risk factor 105
Encephalopathy or hepatic encephalopathy? 105
Body temperature fluctuation analysis in cirrhosis 105
Detection of Minimal Hepatic Encephalopathy: EEG spectral analysis vs. cognitive evoked potentials 104
The Influence of Environmental Factors on Sleep Quality in Hospitalized Medical Patients 103
Hepatitis C virus infection and health-related quality of life. 103
Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): A systematic review and meta-analysis of randomized controlled trials. 102
Between reality and the guidelines: A survey on perception, diagnosis and management of hepatic encephalopathy in 201 Italian specialist centres 102
Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment. 100
Familial vitamin E deficiency: Multiorgan complications support the adverse role of oxidative stress 100
Sleep and circadian abnormalities in patients with cirrhosis: features of delayed sleep phase syndrome? 98
Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis. 97
Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. 97
Simple tools for complex syndromes: A three-level difficulty test for hepatic encephalopathy 97
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF 97
Prognostic benefit of the addition of an electroencephalographic (EEG) index to the MELD score: the MELD-EEG. 96
Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices 96
Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. 95
Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD-EEG 95
Changes in the 24-h plasma cortisol rhythm in patients with cirrhosis. 95
Neuropsychological alterations in hepatitis C infection: the role of inflammation. 95
Improving the inhibitory control task to detect minimal hepatic encephalopathy. 94
What type of probiotic was used? 93
Clinical neurophysiology of hepatic encephalopathy 92
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 92
Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. 91
Endogenous opioids and liver disease. 91
Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. 90
Hepatic decompensation in the absence of obvious precipitants: the potential role of cytomegalovirus infection/reactivation 90
Acute Kidney Injury Network (AKIN) criteria in the detection of renal failure in patients with cirrhosis, ascites and a serum creatinine < 1.5 mg/dl 89
Sleep-wake abnormalities in patients with cirrhosis. 89
Attention: Minimal hepatic encephalopathy and road accidents 88
Agreement and compliance with process measures proposed by the AASLD Practice Metrics Committee: An Italian perspective 88
Bright times for patients with cirrhosis and delayed sleep habits: a case report of the beneficial effect of light therapy 87
On the origin and the consequences of circadian abnormalities in patients with cirrhosis. 87
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition 87
First evidence-based guidelines for the diagnosis and management of hepatic encephalopathy: A welcome development 87
Impulsivity toward food reward is related to BMI: Evidence from intertemporal choice in obese and normal-weight individuals 86
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin 86
Split-brain syndrome after hepatic transplantation: a tacrolimus-related vasculitis? 85
Dietary management of hepatic encephalopathy revisited 85
Neuropsychiatric performance in patients with cirrhosis: Who is “normal”? 85
Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. 85
Hepatic Encephalopathy and Sleepiness: An Interesting Connection? 84
Neuropsychological tools in hepatology: a survival guide for the clinician. 84
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 84
INHIBITORY CONTROL TASK: FOCUS ON THE DETECTION OF MINIMAL HEPATIC ENCEPHALOPATHY, 84
Hepatic encephalopathy: you should only comment on what you have actually measured 83
Resting State Cortical Electroencephalographic Rhythms in Covert Hepatic Encephalopathy and Alzheimer's Disease. 81
Sleep-wake profiles in patients with primary biliary cirrhosis 81
Prevention of the formation and growth of esophageal varices 81
Insight into the relationship between brain/behavioral speed and variability in patients with minimal hepatic encephalopathy 81
The consideration of heart rate complexity as a co-morbidity factor for liver transplantation selection procedures 81
Sleep and Circadian Rhythms in Hospitalized Patients with Decompensated Cirrhosis: Effect of Light Therapy. 80
Abnormalities in the Polysomnographic, Adenosine and Metabolic Response to Sleep Deprivation in an Animal Model of Hyperammonemia 80
Which heart rate variability index is an independent predictor of mortality in cirrhosis 80
Genetic association study of GABRA2 single nucleotide polymorphisms and electroencephalography in alcohol dependence. 79
Primary Prophylaxis of Bleeding from Esophageal Varices in Cirrhosis 79
Characteristics of minimal hepatic encephalopathy 79
Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 79
Covert hepatic encephalopathy: Agreement and predictive validity of different indices 79
Early markers of neural dysfunction and compensation: A model from minimal hepatic encephalopathy 78
Alexithymia, psychopathology and alcohol misuse in adolescence:a population based study on 3556 teenagers 78
Totale 10.551
Categoria #
all - tutte 57.109
article - articoli 54.229
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 956
Totale 112.294


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.771 0 0 0 0 0 219 280 356 389 248 182 97
2020/20212.309 126 173 158 145 146 108 47 247 320 311 270 258
2021/20222.365 78 268 351 131 95 134 137 256 99 76 229 511
2022/20231.637 343 97 27 165 307 205 3 115 231 24 101 19
2023/2024850 61 148 99 60 42 83 40 45 30 30 96 116
2024/20251.220 17 272 188 122 579 42 0 0 0 0 0 0
Totale 15.162